SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2877MNTA Q3 2011 Earnings Call November 7, 2011 Craig Wheeler Thank you, Beverly mopgcw111/12/2011
2876am I the only one who thinks that the more court challenges made by aspiring LovIan@SI-11/7/2011
28754:50PM Momenta Pharma is trading 18.5% higher after hours at $14.50 (see 16:48 cIan@SI-10/28/2011
2874The hybrid model still loves plenty of potential room for good profit sharing. Robohogs-10/25/2011
2873There’s some convoluted argumentation in this thread, IMO. My own opinion is thaDewDiligence_on_SI-10/25/2011
2872I'm not sure about reduced damages, but I don't see the reduced irreparatuck-10/25/2011
2871Well, I don't think anyone including Amphastar was expecting the FDA approvaidos-10/25/2011
2870Look now: I'm seeing $11.75 Cheers, Tucktuck-10/24/2011
2869not much AH volume After Hours Time (ET) After Hours Price After Hours Share Ian@SI-10/24/2011
2868I was not expecting this until Amphastar or Teva hit the market. This is presumtuck-10/24/2011
2867Momenta Pharmaceuticals Announces That Launch of Authorized Generic Lovenox(R) Ian@SI-10/24/2011
2866<i>>The FDA chemist that did the insider trading seems to have a very gDewDiligence_on_SI-10/24/2011
2865The 14 puts were assigned and sold today. The FDA chemist that did the insider semi_infinite -10/24/2011
2864TRO extended another week while the court considers the case.Ian@SI-10/21/2011
2863Momenta Pharmaceuticals to Present at the BioCentury NewsMakers Conference Monmopgcw-10/18/2011
2862The deferral until Oct 20 is not an unexpected outcome. I posted two weeks ago aDewDiligence_on_SI-10/7/2011
2861MNTA gets the TRO. I hadn't expected it. Lack of AH action implies the marIan@SI-10/7/2011
2860Hearing for Temporary Restraining Order and Preliminary Injunction in the Amphastuck-10/4/2011
2859>>Obviously, a is bad for Momenta and b is good. Is it realistic to thinkIRWIN JAMES FRANKEL-10/3/2011
2858nice dig. Thanks for sharing. mopgcw110/2/2011
2857FDA biosimilar pathway. FDA sources says publication of guidelines is imminenttuck-10/1/2011
2856focus on new partnership for their products m118 and m402 and development of FOBmartin2-9/30/2011
2855Momenta Pharmaceuticals Files for Preliminary Injunction Against Amphastar PharIan@SI-9/30/2011
2854<i>My high-view of enablement</i> I'm with you on this one. HowBiomaven-9/28/2011
2853Yes - mC. Sorry for the careless error. I have argued consistently that IMO, tIRWIN JAMES FRANKEL-9/25/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News